Navigation Links
BioRestorative Therapies Provides Company Updates with Shareholder Letter
Date:8/1/2013

m allows for more potential investors interested in purchasing the Company's stock. The Company is extremely pleased to provide investors increased visibility and transparency that this regulated quotation service provides.
  • In late November, BRT launched its new website available at www.biorestorative.com. The new site highlights the Company as an innovator and pioneer in the adult stem cell industry.  The Company's primary programs are highlighted in more detail on the website, along with rich imagery and information about therapies being developed. 
  • At the start of 2013, the Company was invited to present at the Adipose Tissue Biology conference of the Keystone Symposia conference series. Chief Scientist and Vice President of Research and Development, Francisco Silva, presented the Company's research on "Human Metabolically Active Brown Adipose Tissue Derived Stem Cells." This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program, which is in the pre-clinical stage and which focuses on treatments for metabolic disorders (particularly focusing on Type 2 diabetes) and obesity and uses adult derived stem cells from brown adipose (fat) tissue stem cells.
  • On April 13th, Dr. Marasco spoke at the Second International Vatican Adult Stem Cell Conference: Regenerative Medicine -- A Fundamental Shift in Science and Culture. The event was held in Vatican City from April 11th to April 13th. Dr. Marasco spoke during the session entitled "Stem Cells, Cancer and Aging — A Search for Solutions." His talk was titled "What Questions Haven't Been Addressed with Respect to Stem Cells, Cancer and Aging?"
  • In April, the Company was invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in
    '/>"/>

  • SOURCE BioRestorative Therapies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
    2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
    3. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
    4. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
    5. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
    6. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
    7. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
    8. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
    9. BioRestorative Therapies Announces Launch of New Website
    10. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
    11. BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... (PRWEB) March 31, 2015 Diasome Pharmaceuticals, ... licensor, SDG, Inc., that a United States patent has ... insulin therapy. , Entitled “Lipid Construct for ... composition of matter claims related to the use of ... for enabling injected insulin to more effectively reach the ...
    (Date:3/30/2015)... NC (PRWEB) March 30, 2015 ... are pleased to announce the formation of VaxCorps, ... research centers specializing in the conduct of vaccine ... VaxCorps clinical sites have successfully conducted over ... experience in seasonal and pandemic influenza as well ...
    (Date:3/30/2015)... IRVINE, Calif. , March 30, 2015 /PRNewswire/ ... that its subsidiary corporation, NuGene BioPharma, Inc. has ... board. Dr. Guan is an internationally ... After finishing his college education at Peking University, ... his Ph.D. degree from the University of North ...
    (Date:3/30/2015)... 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a commercial focus on China , ... (CFDA) has approved the Company,s application to conduct a ... carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
    Breaking Biology Technology:Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5
    ... , , For transfection of cells with siRNA in RNAi procedures, , , ... , , , , , ... Quick and easy setup , Ready-to-use reagent , ... , , , Principle , , , , ...
    ... , , , , ... Kppers, Gaby Schulte, Silke Zobel, and Dirk Lffert , ... Microsatellites highly polymorphic DNA markers comprised of nucleotides , ... the genome , are a useful tool for ...
    ... , , , Andreas Pahl, Uwe Oelmller,* ... Department of Pharmacology, University of Erlangen, Erlangen, Germany , , ... , , , Drug library screening based on ... purification , and sensitive, quantitative, real-time RT-PCR analysis. This article demonstrates ...
    Cached Biology Technology:TransMessenger Transfection Reagent 2TransMessenger Transfection Reagent 3Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 2Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 3Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 4Fully automated DNA purification and efficient multiplex PCR for analysis , of microsatellite loci 5High-throughput gene expression analysis to screen for anti-asthma drugs 2High-throughput gene expression analysis to screen for anti-asthma drugs 3High-throughput gene expression analysis to screen for anti-asthma drugs 4
    (Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
    (Date:3/12/2015)... WINSTON-SALEM, N.C. , March 12, 2015 ... afternoon at Brenner Children,s Hospital, part of Wake Forest ... an outreach initiative for the 2015 ACC Men,s Basketball ... taking pictures with them and getting their autographs. ... Wake Forest Baptist. It is the only children,s hospital ...
    (Date:3/11/2015)... Research and Markets ( http://www.researchandmarkets.com/research/3p32qm/access_control ) ... Market by Product, Application & By Geography - Global ... offering. , This report predicts that the ... by 2020, with an estimated CAGR of 10.6%. ... types such as contact cards & readers, contactless cards ...
    Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
    ... successfully piloted a process that enables natural resource ... plants and ecosystems as climate changes. The ... practical approach to assessing how future changes in ... and other environmental conditions might affect natural resources. ...
    ... Societies for Experimental Biology (FASEB) is once again calling ... prevent sequestration, the automatic across-the-board budget cuts that are ... automatic spending cuts will stop science advances in their ... FASEB President, Judith S. Bond, PhD. , A ...
    ... MRI and Honorary Lecturer in Cardiovascular Medicine at The University ... the only location in the UK where the trial is ... test manufacturer, to take part in the trial as he ... heart attacks. The other trial sites are in Australia, ...
    Cached Biology News:A game plan for climate change 2A game plan for climate change 3Manchester patients take part in pioneering heart attack blood test trial 2
    Human Apolipoprotein B100 Affinity Purified Polyclonal Ab ENTREZ GeneID: 338...
    Human RXR beta/NR2B2 MAb (Clone H7341) Keywords: RXRbeta, RXRbeta, Retinoid X Receptor beta...
    PSMD1 Antibody...
    Terrific Broth, 1 kg. Mixture of casein peptone, yeast extract, K2HPO4, and KH2PO4.Used at 47 g/l for E. coli growth with higher cell densities. Category: Nucleotides & Enzymes & Biochemicals, Ultrap...
    Biology Products: